Treatment optimisation in drug development (Record no. 5744)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01663nam a22003497a 4500 |
| 001 - CONTROL NUMBER | |
| control field | 00005744 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | ES-MaONT |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20211006062658.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200318s2020 be ||||fst|||i001 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-92-846-6037-7 |
| 024 ## - OTHER STANDARD IDENTIFIER | |
| Source of number or code | doi |
| Standard number or code | 10.2861/114406 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | ES-MaONT |
| 245 04 - TITLE STATEMENT | |
| Title | Treatment optimisation in drug development |
| Remainder of title | : study : Panel for the Future of Science and Technology |
| Statement of responsibility, etc. | / EPRS - European Parliamentary Research Service |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | Brussels : |
| Name of publisher, distributor, etc. | European Union, |
| Date of publication, distribution, etc. | March 2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | V, 70 p. |
| Dimensions | ; 1 documento PDF |
| 336 ## - CONTENT TYPE | |
| Source | isbdcontent |
| Content type term | texto |
| 337 ## - MEDIA TYPE | |
| Source | isbdcontent |
| Media type term | electrónico |
| 338 ## - CARRIER TYPE | |
| Source | rdacarrier |
| Carrier type term | recurso en línea |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Bibliografía: p. 66-70 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The development of novel health technologies is a complex and costly process that follows an extensive set of regulatory guidelines and legal provisions intended to ensure that the treatments reach the patients that need them in a highly controlled and standardised manner |
| 540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE | |
| Terms governing use and reproduction | Reproduction and translation for non-commercial purposes are authorised, provided the source is acknowledged and the European Parliament is given prior notice and sent a copy. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Sanidad digital |
| Source of heading or term | |
| 9 (RLIN) | 2065 |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | treatment optimisation |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | clinical drug |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | treatment |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | patient |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | public health |
| 653 ## - INDEX TERM--UNCONTROLLED | |
| Uncontrolled term | industry |
| 710 ## - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | Parlamento Europeo. |
| Subordinate unit | Dirección General de Servicios de Estudios Parlamentarios |
| 9 (RLIN) | 3675 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | https://www.europarl.europa.eu/RegData/etudes/STUD/2020/641511/EPRS_STU(2020)641511_EN.pdf |
| Nonpublic note | Abierto |
| Link text | Acceso al documento |
| Electronic format type | |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Other/Generic Classification Scheme |
| Koha item type | Informes |
| Withdrawn status | Lost status | Damaged status | Not for loan | Collection code | Koha itemnumber | Home library | Current library | Shelving location | Date acquired | Total Checkouts | Barcode | Date last seen | Price effective from | Koha item type | Public note |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acceso libre online | Colección digital | 6729 | CDO | CDO | 18/03/2020 | 1000020176024 | 18/03/2020 | 18/03/2020 | Informes |